Vinmec successfully developed 2 sets of COVID-19 detection kit
Vinmec Stem Cell Research and Genetic Technology Research Institute (Vingroup Group) has successfully developed 02 sets of SARS-CoV-2 virus test kit (VinKit), reaching the same quality as recommended diagnostic bio-products of the World Health Organization (WHO).
In particular, the VinKit SARS-CoV-2 Multiplex RT-PCR kit was researched and improved by Vinmec, capable of integrating the “3 in 1” reaction, reducing 70% of technical operations, doubling the speed of implementation, ensure high accuracy with low cost.
VinKit SARS-CoV-2 RT-PCR 1.0 and VinKit SARS-CoV-2 Multiplex RT-PCR are 02 kits developed by Vinmec based on the technological process of the US Centers for Disease Control and Prevention (Hoa CDC) United), approved by the FDA (US Food and Drug Administration) in March 2020.
Independent testing results from the Central Institute of Hygiene and Epidemiology, National Institute of Vaccines and Medical Biologicals show that 02 sets of Vinkit are stable, 100% accurate on clinical samples, reaching detection thresholds equivalent to the diagnostic bio-product according to WHO recommendations.
The difference between VinKit SARS-CoV-2 RT-PCR 1.0 and VinKit SARS-CoV-2 Multiplex RT-PCR is the implementation process.
While the VinKit SARS-CoV-2 RT-PCR 1.0 kit operated under CDC’s technological process with three independent reactions to confirm the results; the VinKit SARS-CoV-2 Multiplex RT-PCR set combines three independent reactions into one to save biologicals, time, costs, minimize operations and limit technical errors.
Vinkit SARS-CoV-2 Multiplex RT-PCR Biology kit was developed by Vinmec
VinKit SARS-CoV-2 Multiplex RT-PCR is a product researched and improved by Vinmec, which changes and optimizes the CDC process, and performs only one unique reaction for specific gene regions.
According to testing agencies, VinKit SARS-CoV-2 Multiplex RT-PCR not only achieves 100% accuracy but also meets the following criteria: Clinical specificity, Clinical sensitivity, Analytical specificity (not cross-contaminated with other virus strains), equivalent to those recommended by WHO and CDC.
The Vinkit SARS-CoV-2 Multiplex RT-PCR test kit is suitable for use with many RealTime PCR systems, giving accurate and fast results.
“Thanks to the integrated” 3 in 1 “, VinKit SARS-CoV-2 Multiplex RT-PCR, researched and improved by Vinmec, has reduced 2/3 technical operations, minimized errors during implementation and cost-saving, especially the VinKit SARS-CoV-2 Multiplex RT-PCR kit has increased the testing speed by 2 times compared to other commercially available kits.
This is important in disease control and prevention. At present, we are urgently implementing the production process and carrying out procedures for issuing registration numbers for wide circulation “, Prof. Dr. Nguyen Thanh Liem, Director of Vinmec Stem Cell Research and Gene Technology Institute shared.
With flexible packaging specifications (25, 50 or 100 reactions / compact box); suitable with many Realtime – PCR systems, 02 sets of VinKit have wide applicability at health facilities in the community. Vinmec is ready to cooperate with units to produce large quantities of VinKit, in time to serve the epidemic prevention.
To ensure safety, tests for SARS-CoV-2 virus with VinKit bio-product will be conducted in a laboratory meeting the biosafety standards of level 2.
The SARS-CoV-2 virus testing kit is the second production project of Vingroup to cope with the COVID-19 pandemic. In May 2020, a ventilator developed by Vinsmart Company (of Vingroup Group) with a localization rate of up to 70% was licensed by the Ministry of Health, and awarded to Russia, Ukraine and Singapore.